{"url":"https://lda.senate.gov/api/v1/filings/61c1ceee-a54b-483a-9ef6-e5fa247aeeb6/","filing_uuid":"61c1ceee-a54b-483a-9ef6-e5fa247aeeb6","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/61c1ceee-a54b-483a-9ef6-e5fa247aeeb6/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tazeen Ahmad","dt_posted":"2021-01-06T13:24:13-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"499 South Capitol Street, SW","registrant_address_2":"Suite 608","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":72053,"url":"https://lda.senate.gov/api/v1/registrants/72053/","house_registrant_id":35843,"name":"CAPITOL HILL CONSULTING GROUP","description":"Government Relations Firm","address_1":"926 Pennsylvania Ave, SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAZEEN AHMAD","contact_telephone":"+1 202-488-0101","dt_updated":"2026-02-12T13:35:33.453852-05:00"},"client":{"id":207897,"url":"https://lda.senate.gov/api/v1/clients/207897/","client_id":1006587,"name":"NOVALENT","general_description":"FDA policy on personal care products.","client_government_entity":false,"client_self_select":null,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA policy on personal care products.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":27186,"prefix":null,"prefix_display":null,"first_name":"JACK","nickname":null,"middle_name":null,"last_name":"VICTORY","suffix":null,"suffix_display":null},"covered_position":"Senior Advisor, Majority Leader Tom DeLay- 1/02 -05. Policy Advisor, Tom DeLay - 5/ 2001-1/2002. LD, Rep. Jim Gibbons - 6/98 - 5/01. Senior LA, Systems Administrator, Rep Richard Pombo (1/95 - 12/96)","new":true},{"lobbyist":{"id":71228,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"ELIZABETH","last_name":"WILKINSON-HOLLAND","suffix":null,"suffix_display":null},"covered_position":"Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}